Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosbretabulin for CNV in Pathologic Myopia
NCT01423149Phase 2Completed
- Sponsor
- Oncotelic Therapeutics, Inc.
- Start
- Mar 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fosbretabulin in choroidal neovascularization (CNV), sponsored by Oncotelic Therapeutics, Inc.. Started Mar 2005; status: completed.
02
Drugs
fosbretabulin
03
Conditions
choroidal neovascularization (CNV)
Beyond the preview
Go deeper on NCT01423149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01423149.